Journal of Pharmaceutical Investigation

, Volume 43, Issue 2, pp 133–143 | Cite as

Mathematical optimization and characterisation of pharmaceutically developed novel buccoadhesive wafers for rapid bioactive delivery of Loratadine

  • Prithviraj Chakraborty
  • Versha Parcha
  • Debarupa D. Chakraborty
  • Indranil Chanda
  • Amitava Ghosh
Research Article


The purpose of this study was to develop pharmaceutically active buccoadhesive wafer formulations containing Loratadine and mathematically optimize the influence of bioadhesive polymer Sod. CMC and Lactose monohydrate as an ingredient of wafer base matrix, on the physicochemical and drug release performance from the prepared wafers. The wafers, which were prepared by the solvent casting method, were smooth and elegant in appearance; uniform in thickness, weight and drug content; showed no visible cracks; and demonstrated good folding endurance. A 32 factorial design was employed to study the effect of independent variables like Sod.CMC and Lactose monohydrate, which significantly influenced characteristics like buccoadhesion, swelling index, disintegration time and t70 % of the prepared wafers. The drug-excipients interaction studies performed by ATR-FTIR, DSC and XRD revealed drug polymer compatibility within the wafer formulation. Surface morphology of the prepared wafers were studied by using SEM. Drug release study in the buccal environment showed the efficacy of the wafers to release drug within a very short span of time. Thus a conclusion might be brought forward that the present buccal wafer formulation could be an ideal system improving the bioavailability of the drug by avoiding hepatic first pass metabolism and would be an ideal alternative for the patients suffering with dysphagia.


Wafer Mathemetical optimization  Buccoadhesive RSM Loratadine 



The authors are thankful to Department of Pharmaceutical Sciences; Dibrugarh University, Assam, India, for providing DSC facility, Department of Metallurgy, Jadavpur University, Kolkata, India for providing SEM and XRD facilities and Prof. (Dr.) S.K Dash and Mr. Pulak Deb, Girijananda Institute of Pharmaceutical Sciences, Guwahati, Assam, India, for providing TAXT2i Texture Analyzer facility.


  1. Aboelwafa AA, Basalious EB (2010) Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet. AAPS PharmSciTech 11:1026–1037PubMedCrossRefGoogle Scholar
  2. Abu-Lathou A, Hamdan II, Tahraoui A (2005) A new HPLC approach for the determination of hydrophilic and hydrophobic components: the case of pseudoephedrine sulfate and Loratadine in tablets. Drug Dev Ind Pharm 31:577–588PubMedCrossRefGoogle Scholar
  3. Ahmad FJ, Alam MA, Khan ZI, Khar RK, Ali M (2008) Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm 58:407–419PubMedCrossRefGoogle Scholar
  4. Akhgari A, Garekani HA, Sadeghi F, Azimaie M (2005) Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm 305:22–30PubMedCrossRefGoogle Scholar
  5. Boateng JS, Matthews KH, Auffret AD, Humphrey MJ, Stevens HN, Eccleston GM (2009) In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug. Int J Pharm 378:66–72PubMedCrossRefGoogle Scholar
  6. Bottenberg P, Cleymaet R, deMynck CO, Remen JP, Coomans D, Michotte Y, Slop D (1991) Development and testing of bioadhesive fluoride containing slow release tablets for oral use. J Pharm Pharmacol 43:457–464PubMedCrossRefGoogle Scholar
  7. Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L (2008) Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 70:895–900PubMedCrossRefGoogle Scholar
  8. de Vries ME, Bodde HE, Verhoef JC, Junginger HE (1991) Development in buccal drug delivery. Crit Rev Ther Carr Syst 8:271–303Google Scholar
  9. Dhiman MK, Yedurkar PD, Sawant KK (2008) Buccal bioadhesive delivery system of 5-fluorouracil: optimization and characterization. Drug Dev Ind Pharm 34:761–770PubMedCrossRefGoogle Scholar
  10. El-Meshad AN, El-Hagrasy AS (2011) Characterization and optimization of orodispersible mosapride film formulations. AAPS PharmSciTech 12:1384–1392CrossRefGoogle Scholar
  11. El-Setouhy DA, El-Malak NSA (2010) Formulation of a novel tianeptine sodium orodispersible film. AAPS PharmSciTech 11:1018–1025PubMedCrossRefGoogle Scholar
  12. Garsuch V, Breitkreutz J (2009) Novel analytical methods for characterization of oral wafers. Eur J Pharm Biopharm 73:195–201PubMedCrossRefGoogle Scholar
  13. Gelfand EW, Appajosyula S, Meeves S (2004) Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research. Cur Med Res Opin 20:73–81CrossRefGoogle Scholar
  14. Hao J, Heng PWS (2003) Buccal delivery systems. Drug Dev Ind Pharm 29:821–832PubMedCrossRefGoogle Scholar
  15. Hassan N, Ali M, Ali J (2010) Novel buccal adhesive system for anti-hypertensive agent nimodipine. Pharm Dev Tech 15:124–130CrossRefGoogle Scholar
  16. Hoffmann EM, Breitenbach A, Breitkreutz J (2011) Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv 8:299–316PubMedCrossRefGoogle Scholar
  17. Kemp W. Organic spectroscopy, 3rd edn. Replika Press Pvt. Ltd, Haryana. Reprint 2009, pp 29–39; 2011, pp 60–76Google Scholar
  18. Koland M, Charyulu RN, Vijayanarayana K, Prabhu P (2011) In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride. Int J Pharm Investig 1:164–171PubMedCrossRefGoogle Scholar
  19. Kunamneni A, Kuttanpillai SK, Singh S (2005) Response surface methodological approach to optimize the nutritional parameters for enhanced production of α-amylase in solid state fermentation by Thermomyces lanuginosus. Afr J Biotech 4:708–716Google Scholar
  20. Morales JO, McConville JT (2011) Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm 77:187–199PubMedCrossRefGoogle Scholar
  21. Munasur AP, Pillay V, Chetty DJ, Govender T (2006) Statistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapy. Int J Pharm 323:43–51PubMedCrossRefGoogle Scholar
  22. Nafee NA, Boraie NA, Ismail FA, Mortada LM (2003a) Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm 53:199–212PubMedGoogle Scholar
  23. Nafee NA, Ismail FA, Boraie NA, Mortada LM (2003b) Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm 264:1–14PubMedCrossRefGoogle Scholar
  24. Onozawa A, Kikukawa A, Miyamoto Y (2008) A new evaluation method for +Gz tolerance with loratadine by using a near-infrared spectroscopy. Dyn Med 7:3. doi: 10.1186/1476-5918-7-3 PubMedCrossRefGoogle Scholar
  25. Saigal N, Baboota S, Ahuja A, Ali J (2008) Fast-dissolving intra-oral drug delivery systems. Expert Opin Ther Pat 18:769–781CrossRefGoogle Scholar
  26. Sudhakar Y, Kuotsu K, Bandyopadhyay AK (2006) Buccal bioadhesive drug delivery: a promising option for orally less efficient drugs. J Control Release 114:15–40PubMedCrossRefGoogle Scholar
  27. Szabados-Nacsa A, Sipos P, Martinek T, Mandity I, Blazso G, Balogh A, Szabo-Revesz P, Aigner Z (2011) Physico-chemical characterization and in vitro/in vivo evaluation of loratadine: dimethyl-β-cyclodextrin inclusion complexes. J Pharm Biomed Anal 55:294–300PubMedCrossRefGoogle Scholar
  28. Wang J, Wu FA, Liang Y, Wang M (2010) Process optimization for the enrichment of α-linolenic acid from silkworm pupal oil using response surface methodology. Afr J Biotech 9:2956–2964Google Scholar

Copyright information

© The Korean Society of Pharmaceutical Sciences and Technology 2013

Authors and Affiliations

  • Prithviraj Chakraborty
    • 1
  • Versha Parcha
    • 2
  • Debarupa D. Chakraborty
    • 1
  • Indranil Chanda
    • 3
  • Amitava Ghosh
    • 1
  1. 1.Bengal College of Pharmaceutical Sciences and ResearchDurgapurIndia
  2. 2.Department of ChemistrySardar Bhagwan Singh PG Institute of Biomedical Sciences and ResearchDehradunIndia
  3. 3.Girijananda Chowdhury Institute of Pharmaceutical ScienceGuwahatiIndia

Personalised recommendations